Bildkälla: Stockfoto

Scandion Oncology: Initial reaction to CORIST phase II interim results - Redeye

Redeye gives its initial impressions about Scandion’s release of positive CORIST phase II interim results. Following the scheduled audiocast at 10 am, we will come back with a more detailed note later today.

Redeye gives its initial impressions about Scandion’s release of positive CORIST phase II interim results. Following the scheduled audiocast at 10 am, we will come back with a more detailed note later today.
Börsvärldens nyhetsbrev
ANNONSER